Cochrane Renal Group

 Back
autoid 91
crg_id CRG010600028
titleoftrial Loss of body weight in pre-dialysis end-stage renal disease patients: Relationship between the changes in body composition and insulin resistance
acronymnoftrial
website http://
identificationno
leadprefix Dr
leadsurname Lee
leadgivennames Seoung Woo
leadposition Associate professor
leaddepartment Division of Nephrology and Hypertension, Department of Internal medicine
leadorganisation Inha University College of Medicine,
leadaddress 7-206, 3-Ga, Sinhung-Dong, Jung-Gu, Incheon City, Republic of Korea
leademail swleeinha2002@yahoo.co.kr
leadphone +82 32 890 2537
leadfax +82 32 882 6578
leadsuffix
contactprefix
contactsurname
contactgivennames
contactposition
contactdepartment
contactorganisation
contactaddress
contactemail
contactphone
contactfax
funding other
otherfunding Inha University Research Grant
fundingnameofsponsors
ethicsapproval yes
studytype nonrandomised
studytype_other Cross-sectional study
groupassignment
blinding_patients no
blinding_investigators no
blinding_outcomes no
blinding_analysts no
proposedstart 03/2004
actualstart 05/2004
proposedcompletiondate 03/2005
actualcompletiondate 08/2005
multi_center_study no
numberofcentres
multi_national_study no
countrycentres Republic of Korea
researchquestion To determine the relationship between the changes in body composition and insulin resistance in patients with pre-dialysis ESRD patients
study_status_recruitment no_longer_recruiting
study_status_recruitment_follow completed
healthcarecondition End-stage renal disease patients for the initiation of dialysis
intervention1
intervention2
intervention3
intervention4
participants_gender both
participants_other adults
age N/A
totalrecruitment N/A
inclusion Non-diabetic ESRD patients who were admitted for the initiation of dialysis
exclusion Current acute illness (including infectious disease), diabetic nephropathy, serum C reactive protein (CRP) of more than 0.30 mg/dL, medical history of cardiovascular disease (cardiac, cerebral, or peripheral vascular disease), cancer, administration of recombinant human erythropoietin, growth hormone or anabolic steroid, or refusal to participate in the study
primaryoutcomes Relationship between insulin resistance and the body composition
secondaryoutcomes Factors influencing insulin-resistance in pre-dialysis ESRD patients
reference